# Remicade in the Treatment of Patients With Active Ankylosing Spondylitis

> **NCT01850121** · — · COMPLETED · sponsor: **Göteborg University** · enrollment: 19 (actual)

## Conditions studied

- Ankylosing Spondylitis

## Interventions

- **DRUG:** Infliximab

## Key facts

- **NCT ID:** NCT01850121
- **Lead sponsor:** Göteborg University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2003-01
- **Primary completion:** 2008-05
- **Final completion:** 2008-05
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2016-08-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01850121

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01850121, "Remicade in the Treatment of Patients With Active Ankylosing Spondylitis". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01850121. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*